Nav: Home

Current Chemotherapy News and Events

Current Chemotherapy News and Events, Chemotherapy News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Study finds new way to make chemotherapy more effective against pancreatic cancer
Pancreatic adenocarcinoma (PDAC) is a lethal malignancy that most often is resistant to chemotherapy. (2019-09-18)
Cancer cells turn to cannibalism to survive chemotherapy, study suggests
Researchers from the Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells. (2019-09-17)
Novel anti-cancer nanomedicine for efficient chemotherapy
Researchers have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy. (2019-09-17)
Cosmetic changes are equivalent after WBI vs PBI for women with early stage breast cancer
Results from the Quality of Life substudy of the NRG Oncology clinical trial NSABP B-39/RTOG 0413 indicate that women rated post-lumpectomy partial breast irradiation (PBI) as equivalent to whole breast irradiation (WBI) in terms of cosmetic outcomes and satisfaction from baseline to three years following radiotherapy treatment. (2019-09-16)
Scientists discover new breakthrough in cancer hair loss treatment
Researchers based at The University of Manchester have discovered a new strategy for how to protect hair follicles from chemotherapy, which could lead to new treatments that prevent chemotherapy-induced hair loss -- arguably one of the most psychologically distressing side effects of modern cancer therapy. (2019-09-12)
Bone marrow may be the missing piece of the fertility puzzle
A woman's bone marrow may determine her ability to start and sustain a pregnancy, report Yale researchers in PLOS Biology. (2019-09-12)
Breaking the 'stalemate' in the most common soft tissue sarcoma in children
Rhabdomyosarcoma is the most common soft tissue sarcoma in children. (2019-09-12)
IMpower131
Patients with Stage IV squamous non-small cell lung cancer enrolled in clinical trial to test the immunotherapy atezolizumab and chemotherapy against chemotherapy alone experienced a longer survival rate, among a subgroup of patients with high PD-LI. (2019-09-10)
KEYNOTE-024 three-year survival update
First line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. (2019-09-10)
Patients taking nivolumab experience five-fold increase in overall survival compared to chemotherapy
Pooled data on two clinical trials demonstrate patients taking nivolumab realized a greater than five-fold increase in five-year overall survival rate compared with the chemotherapy docetaxel. (2019-09-10)
Precious metal flecks could be catalyst for better cancer therapies
Tiny extracts of a precious metal used widely in industry could play a vital role in new cancer therapies. (2019-09-09)
New KEYNOTE 021 data shows no association with tumor mutational burden
Researchers had previously reported data from the KEYNOTE 021 trial that showed antitumor activity for pembrolizumab plus platinum-based chemotherapy in untreated advanced nonsquamous non-small cell lung cancer patients. (2019-09-08)
Keynote 189: Tumor mutational burden not significantly associated with efficacy of pembrolizumab
Tumor mutational burden was not significantly associated with efficacy of pembrolizumab plus chemotherapy or placebo plus chemotherapy as first-line therapy for metastatic nonsquamous non-small cell lung cancer, according to research reported today by Dr. (2019-09-08)
Role of cancer protein ARID1A at intersection of genome stability and tumor suppression
The ARID1A tumor suppressor protein is required to maintain telomere cohesion and correct chromosome segregation after DNA replication. (2019-09-06)
Discovered the potential of antihistamines that cause the death of leukaemic stem cells
The IJC Leukaemic Stem Cell research group, led by Ruth M. (2019-09-06)
FAK protein linked to chemotherapy resistance in ovarian cancer
A new University of California San Diego School of Medicine study links changes in the gene for the protein focal adhesion kinase, or FAK, to ovarian cancer's ability to survive chemotherapy. (2019-09-03)
Oncologists echo findings that suggest a reduced risk of breast cancer recurrence
Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncology providing expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast cancer. (2019-08-26)
Genetically manipulating protein level in colon cancer cells can improve chemotherapy
Colorectal cancer outcomes may improve by genetically altering an immune-regulatory protein in cancer cells, making the cells more vulnerable to chemotherapy. (2019-08-26)
Novel combination of drugs may overcome drug-resistant cancer cells
A new study led by investigators from Brigham and Women's Hospital suggests that a combination of three drugs, including a new class of glucose-6-phosphate dehydrogenase inhibitors, could overcome cross-therapy resistance. (2019-08-20)
Researchers identify protein governing platinum resistant ovarian cancer
Researchers at the GW Cancer Center have identified the protein ERK as an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer. (2019-08-16)
Chemical screening suggests a two-pronged treatment for pediatric Ewing sarcoma
For children with Ewing sarcoma, an aggressive bone cancer, a combination of two different classes of drugs may work synergistically to turn off the drivers fueling this disease, finds a new study. (2019-08-14)
Exercise associated with benefit to patients with advanced colorectal cancer
Patients with metastatic colorectal cancer who engaged in moderate exercise while undergoing chemotherapy tended to have delayed progression of their disease and fewer severe side effects from treatment, according to the results of a new study. (2019-08-14)
Risks of novel oral prostate cancer therapies and pre-existing conditions
Common prostate cancer therapy may increase short-term risk of death in patients with pre-existing cardiovascular conditions. (2019-08-13)
Key to targeting the spread of pancreatic cancer
Targeting the tissue around pancreatic cancer cells may be the key to stopping their spread and improving chemotherapy outcomes. (2019-08-12)
Personalized assay surpasses limits for detecting tumor DNA in breast cancer patients
Scientists have developed a personalized platform tailored to patients' specific cancer mutations named TARDIS, which was able to accurately detect circulating tumor DNA (ctDNA) and signs of residual disease in 33 women with breast cancer. (2019-08-07)
Chemotherapy drugs react differently to radiation while in water
In a new study in EPJ D, researchers at the Leopold-Franzens-University Innsbruck, in Innsbruck, Austria studied the way various molecules, found in chemotherapy drugs, react to ionization by radiation similar to that used in cancer treatment. (2019-08-07)
Lymph nodes can predict survival in patients with esophageal cancer
It is difficult for physicians to estimate recurrence and survival in patients with esophageal cancer. (2019-07-29)
New drug providing hope for babies with aggressive Acute Lymphoblastic Leukaemia
A breakthrough new drug is providing hope to tiny babies at risk of dying from an aggressive form of Acute Lymphoblastic Leukaemia and could help all cancer patients. (2019-07-27)
Targeting old bottleneck reveals new anticancer drug strategy
The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. (2019-07-22)
Delay from breast cancer diagnosis to chemotherapy after an operation may shorten survival
Women with breast cancer should start postoperative chemotherapy, when recommended, ideally within four months of their cancer diagnosis because new study findings show that waiting longer is associated with poorer overall survival. (2019-07-22)
'Trojan horse' anticancer drug disguises itself as fat
A stealthy new drug-delivery system disguises chemotherapeutics as fat in order to outsmart, penetrate and destroy tumors. (2019-07-18)
Biomaterial-delivered chemotherapy leads to long-term survival in brain cancer
A combination of chemotherapy drugs during brain cancer surgery using a biodegradable paste, leads to long-term survival, researchers at the University of Nottingham have discovered. (2019-07-18)
Study finds key metabolic changes in patients with chemotherapy-associated cardiotoxicity
Researchers at Beth Israel Deaconess Medical Center embarked on a study to investigate whether early changes in energy-related metabolites in the blood -- measured shortly after chemotherapy -- could be used to identify patients who developed heart toxicity at a later time. (2019-07-18)
Heart drug could increase survival rates for children with aggressive form of brain tumor
Researchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for children with ependymoma - a type of brain tumour. (2019-07-16)
Cancer device created at rutgers to see if targeted chemotherapy is working
Rutgers researchers have created a device that can determine whether targeted chemotherapy drugs are working on individual cancer patients. (2019-07-16)
Combined breast and gynecologic surgery: Study says not so fast
University of Colorado Cancer Center study published in Breast Journal argues against combined approach: Patients undergoing coordinated breast and gynecologic procedures had a significantly longer length of hospital stay, and higher complication, readmission, and reoperation rates compared with patients who underwent single site surgery. (2019-07-15)
Unlocking chemo-resistance in cancer
Associate Professor Hamsa Puthalakath's explanation of why some cancers don't respond to treatment with one of the most effective chemotherapy drugs: 5-Fluorouracil (5-FU) has the potential to lead to: a lab test to check for 5-FU resistance, which would reduce unnecessary chemotherapy treatments; a new drug to turn off 5-FU in resistance; and he finds 5-FU resistance is linked to a the protein 'BOK,' the function of which has stumped scientists for decades. (2019-07-15)
Killing the seeds of cancer: A new finding shows potential in destroying cancer stem cells
When doctors remove a tumor surgically or use targeted therapies, the cancer may appear to be gone. (2019-07-08)
Mechanism behind low cancer occurrence in bats signals potential treatment strategies for humans
Researchers from Duke-NUS Medical School have uncovered a potential mechanism behind cancer suppression in bats that may lead to future therapies for human cancers. (2019-07-03)
New study showing drug prolongs life for patients with ovarian cancer
Women with ovarian cancer who have undergone four or more rounds of chemotherapy typically haven't had much hope that another treatment option will lengthen their lives in a meaningful way. (2019-07-02)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...